About Orano Med
|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
700 Klein Road, Plano, TX 75074, US
|
|
Based on an R&D program started in 2005 by our founder, Patrick Bourdet, Orano Med has developed new processes for producing high-purity lead-212, a rare radioactive isotope. Lead-212 is currently at the heart of promising research projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells.
Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information please visit www.macrocyclics.com.
|
Orano Med Email Format
The widely used Orano Med email format is {f}{last}@oranomed.com (e.g. [email protected]), which is used 75.00% of the time.
| Orano Med Email Formats | Example Email Formats | Percentage |
|---|---|---|
| {f}{last} | [email protected] |
75.00%
|
Orano Med Alternatives
Frequently Asked Questions about Orano Med
What is Orano Med email format?
The widely used Orano Med email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
What is Orano Med customer service number?
To contact Orano Med customer service number in your country click here to find.
Who is the CEO of Orano Med?
Julien Dodet is the CEO of Orano Med. To contact Julien Dodet email at [email protected] or [email protected].
Orano Med Staff Directory
Search Orano Med Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Search Portal
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
